Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlus500 Regulatory News (PLUS)

Share Price Information for Plus500 (PLUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,180.00
Bid: 2,178.00
Ask: 2,186.00
Change: 18.00 (0.83%)
Spread: 8.00 (0.367%)
Open: 2,156.00
High: 2,192.00
Low: 2,154.00
Prev. Close: 2,162.00
PLUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

13 Jun 2023 08:01

RNS Number : 5302C
Plus500 Limited
13 June 2023
 

13 June 2023

Plus500 Ltd.

("Plus500" or "the Company")

Transaction in Own Shares

Plus500, a global multi-asset fintech group operating proprietary technology-based trading platforms, announces that it has purchased 7,327,605 ordinary shares of ILS 0.01 each in the Company ("Ordinary Shares") from Odey Asset Management LLP (the "Purchase"), representing approximately 8.2% of the Company's issued share capital (excluding shares already held in treasury), at a price of 1,383 pence per Ordinary Share, for a total consideration of approximately £101.3 million. The acquired shares will be held in treasury.

Given the significant strength of the Company's balance sheet and the prevailing circumstances, the Board believes the Purchase is in the best interest of all shareholders. The Company has acted quickly to execute this opportunity to acquire shares at an attractive price, in-line with the Company's capital allocation and shareholder return policy. As announced on 19 April 2023, the Company had cash balances of over $950 million as at 31 March 2023.

The Purchase has been conducted separately from the Company's latest share buyback programme to purchase up to $70.0 million of the Company's Ordinary Shares, announced on 14 February 2023 (the "Share Buyback Programme"), which will continue as planned. As at 12 June 2023, the Company had repurchased approximately $52 million of the Company's Ordinary Shares pursuant to the Share Buyback Programme.

Following the Purchase, the Company has authority to make further purchases of up to 683,244 Ordinary Shares pursuant to the authority granted to it at the Company's 2023 AGM, held on 2 May 2023.

Total Voting Rights

The Company will hold the repurchased shares in treasury. Following the Purchase, the remaining number of Ordinary Shares in issue will be 82,512,335 (excluding treasury shares), and the Company will hold 32,376,042 Ordinary Shares in treasury. Therefore, the total voting rights in Plus500 will be 82,512,335. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further details

Plus500 Ltd.

Elad Even-Chen, Chief Financial Officer

 

+972 4 8189503

ir@Plus500.com

Dentons Global Advisors

James Melville-Ross

James Styles

Leah Dudley

+44 (0)20 7664 5095

plus500@dentonsglobaladvisors.com

 

 

 

About Plus500

 

Plus500 is a global multi-asset fintech group operating proprietary technology-based trading platforms. Plus500 offers customers a range of trading products, including OTC ("Over-the-Counter" products, namely Contracts for Difference (CFDs)), share dealing, as well as futures and options on futures. The Group retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the Seychelles, the United States, Estonia, Japan and the UAE and through its OTC product portfolio, offers more than 2,500 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group can trade its OTC products in more than 50 countries and in 30 languages. Plus500 does not permit customers located in the US to trade its OTC products. Plus500 does not utilise cold calling techniques and does not offer binary options. Plus500's trading platforms are accessible from multiple operating systems (Windows, iOS and Android) and web browsers. Customer care is and has always been integral to Plus500, as such, OTC customers cannot be subject to negative balances. A free demo account is available on an unlimited basis for OTC trading platform users and sophisticated risk management tools are provided free of charge to manage leveraged exposure and stop losses to help customers protect profits, while limiting capital losses. Plus500 shares have a premium listing on the Main Market of the London Stock Exchange (symbol: PLUS) and are a constituent of the FTSE 250 index. www.plus500.com.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR"). Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGLGDLCUBDGXX
Date   Source Headline
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSQ1 2024 Trading Update
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNS2023 Annual Report and 2024 Annual General Meeting
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSShare Buyback Programme Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.